The global esophageal implant market size is estimated to reach US$ 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, total market value is likely to exceed US$ 280.2 million.
Implants used to treat various esophageal disorders such as gastroesophageal reflux disease (GERD) and esophageal strictures are referred to as esophageal implants. These include esophageal stents, artificial esophageal valves, magnetic sphincter augmentation devices, and injectable bulking agents.
Usage of esophageal implants significantly improves the quality of life in patients suffering from esophageal problems. This is due to their ability to relieve various symptoms and reduce need for medical therapies (acid pills, etc.).
The market growth is being propelled due to the rising need for surgical resection of the esophagus as a result of cancer, trauma, or birth defects.
As per the Centers for Disease Control and Prevention, around one child suffers from esophageal atresia in every 4,100 children born in the United States. This birth condition can occur on its own, although it is more commonly associated with other birth problems. Such escalating faults are important drivers fueling market expansion.
Esophageal implants have emerged as the most effective treatment for a variety of illnesses, including GERD and esophageal strictures. As a result of the increasing efficacy of these implants in therapies, the demand for esophageal implants is increasing.
Rising patient inclination towards minimally invasive procedures is another key factor that is expected to fuel esophageal implant demand globally. Subsequently, growing popularity of biodegradable stents and hybrid implants is likely to support market expansion.
Leading esophageal implant manufacturers are concentrating on developing new innovative solutions with several advantages. For instance, to treat esophageal atresia and other esophageal disorders, Biostage is developing its Cellspan esophageal implant.
These new implants can significantly improve patient outcomes by potentially simplifying surgical techniques to reduce post-operative complications, enhance quality of life, and enable regeneration of the patient’s own esophagus.
Attributes | Key Insights |
---|---|
Estimated Global Esophageal Implant Market Size (2023) | US$ 147.0 million |
Projected Esophageal Implant Market Value (2033) | US$ 280.2 million |
Value-based CAGR (2023 to 2033) | 6.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Challenges for Companies /Manufacturers in the Esophageal Implant Industry:
Opportunities in the Esophageal Implant Industry:
Latest Trends in the Esophageal Implant Market:
According to Future Market Insights’ (FMI) latest report, global sales of esophageal implants increase at a CAGR of 5.6% from 2017 to 2022. Total market size reached US$ 139.1 million in 2022.
From 2017 to 2022, the global esophageal implant industry witnessed steady growth due to the rising preference for esophageal implants for treatments.
Initially, surgery was the only option for treating tracheoesophageal fistula (TEF). Although this is still true for benign TEF and other disorders, implantation of esophageal implant is currently the preferred treatment for both malignant and benign TEF when surgery cannot be delayed.
Self-expanding metal stents (SEMS) have been the preferred stent since the mid-1990s, replacing hard plastic prostheses.
Looking ahead, the global esophageal implant industry is expected to rise at a CAGR of 6.7% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 280.2 million.
Growth in the market is expected to be driven by rising cases of esophageal disorders, innovations in esophageal implants, and a strong desire for minimally invasive procedures.
Introduction of several medical innovations and rising demand for implants & therapies involving minimally invasive surgery will further boost the market.
Growing Awareness Regarding Treatment of Esophageal Disorders Fueling Demand in the United States
Country | United States |
---|---|
Market Size (US$ million) by End of Forecast Period (2033) | US$ 105.2 million |
CAGR % from 2023 to End of Forecast (2033) | 7.3% |
As per Future Market Insights (FMI), the United States esophageal implant industry is expected to reach a valuation of US$ 105.2 million by 2033. From 2023 to 2033, esophageal implant sales in the country are likely to surge at 7.3% CAGR.
The United States esophageal implant industry is predicted to expand due to the country's high knowledge of esophageal disease management and treatment. This encourages key firms to develop and launch new products, which will ultimately help them expand their market.
Favorable legislation, presence of significant esophageal stent suppliers, new product releases, and the use of cutting-edge technology are other factors boosting the United States market.
Similarly, rising cases of GERD is likely to elevate esophageal implant demand during the projection period.
Prevalence of Esophageal Cancers to Retain High Demand for Esophageal Stents the United Kingdom
Country | The United Kingdom |
---|---|
Market Size (US$ million) by End of Forecast Period (2033) | US$ 14.11 million |
CAGR % from 2023 to End of Forecast (2033) | 5.6% |
The United Kingdom esophageal implant industry is forecast to attain a valuation of US$ 14.11 million by 2033. Total esophageal implant demand in China is projected to rise at 5.6% CAGR during the forecast period.
Growth in the market is expected to be driven by rising prevalence of esophageal cancer in the country.
Esophageal stents are eventually employed by doctors to open up a blockage caused by cancer. This aids in the relief of symptoms produced by the obstruction.
Increasing Cases of Dysphagia to Bolster Esophageal Implant Sales in China
Country | China |
---|---|
Market Size (US$ million) by End of Forecast Period (2033) | US$ 21.34 million |
CAGR % from 2023 to End of Forecast (2033) | 8.6% |
As per Future Market Insights (FMI), esophageal implant sales in China are anticipated to soar at 8.6% CAGR through 2033. Total market valuation in China at the end of 2033 is expected to reach US$ 21.34 million.
The esophageal implant industry in China is likely to expand prominently due to the high prevalence of dysphagia.
Dysphagia is becoming more common in China, especially among the elderly and those who have had strokes. To treat this medical condition, esophageal implants such as stents are being used.
Rising Instances of Barrett’s Esophagus Disease to Elevate Esophageal Implant Demand in Japan
Country | Japan |
---|---|
Market Size (US$ million) by End of Forecast Period (2033) | US$ 4.4 million |
CAGR % from 2023 to End of Forecast (2033) | 7.5% |
Japan esophageal implant industry is estimated to reach a valuation of US$ 4.4 million by 2033. It is likely to thrive at a CAGR of 7.5% during 2023 to 2033. The market in Japan is predicted to expand because of the increasing geriatric population.
Japan has one of the world's leading shares of geriatric population. The risk of esophageal disorders such as esophageal cancer, gastroesophageal reflux disease (GERD), and Barrett's esophagus increase with age. These diseases often necessitate surgery and the use of esophageal implants.
Increasing Government Support for Development of Medical Devices to Boost Korea Market
Country | South Korea |
---|---|
Market Size (US$ million) by End of Forecast Period (2033) | US$ 0.7 million |
CAGR % from 2023 to End of Forecast (2033) | 6.9% |
The Korea esophageal implant industry is poised to exhibit a CAGR of 6.9% during the projection period. Total market valuation in Korea is projected to reach US$ 0.7 million by 2033.
The market in South Korea is forecast to witness robust growth due to favorable government support for product development. Through different initiatives and funding support, the South Korean government has aggressively fostered the development of the medical device industry.
Financial incentives, research grants, and tax breaks are available to enterprises engaged in medical device research and development. Because of the government's commitment to supporting innovation in the healthcare sector, both domestic and foreign enterprises have invested in medical device development.
Esophageal Stents to Create the Most Profitable Opportunities for Manufacturers
According to Future Market Insights (FMI), esophageal stents segment is expected to dominate the global market. It is likely to thrive at a CAGR of 6.0% from 2023 to 2033, making it a key revenue-generation segment.
Growth of the target segment is driven by rising usage of esophageal stents for treating various conditions due to their less postoperative difficulties.
Esophageal stents have become key tools for palliative treatment of inoperable esophageal malignancies. They are mostly placed in the esophagus to keep blocked areas open. These stents can also be used to treat conditions such as esophageal fistulas, strictures, leaks, and perforations.
Development of advanced stents by manufacturers to lower the operative risks in patients will further boost the target segment.
Leading esophageal implant manufacturers are introducing novel products that are safe and easy to use. For instance, BONASTENT is an esophageal stent product. It has an anatomically adjustable nitinol hook and cross-wire construction. Its outspread and returning forces are appropriate for excellent conformability.
Growing popularity of bioabsorbable stents is another factor that is expected to boost growth of the target segment.
Gastroesophageal Reflux Disease (GERD) Treatment Application to Lead the Market
Application in treatment of gastroesophageal reflux disease (GERD) is expected to dominate the esophageal implant industry, exhibiting a CAGR of 7.4% from 2023 to 2033. This is due to rising prevalence of GERD coupled with increasing usage of esophageal implants for treating this medical condition.
Numerous studies have found that one of the main causes of GERD disease is obesity or excess belly fat. Over 20% of persons in the United States suffer from GERD as a result of being overweight or obese. This in turn is likely to elevate esophageal implant demand during the assessment period.
Hospitals Remain the Leading End User of Esophageal Implants
As per the latest report, hospitals will remain the leading end-users of esophageal implants. The target segment is likely to progress at a CAGR of 7.1% from 2023 to 2033. This is due to the presence of high skilled professionals in the hospitals and rising patient inclination on getting treatments in hospitals.
Hospitals continue to be the most widely used setting for doing minimally invasive procedures for gastrointestinal diseases. The existence of cutting-edge infrastructure and qualified medical personnel is what drives demand for esophageal implants in hospitals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The esophageal implant industry is highly competitive due to large presence of regional and local players. In such a scenario, companies must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players:
Companies are investing rigorously in research and development to introduce new products with enhanced features. Product innovation enables manufacturers to differentiate themselves from their competitors and meet the evolving needs of customers.
Key players in the industry often form strategic alliances, collaborations, and partnerships with other companies to leverage their strengths and expand their reach in the market.
The esophageal implant industry is witnessing significant growth in emerging markets such as China and India. Key esophageal implant manufacturers are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks.
Key esophageal implant companies are also adopting mergers and acquisitions to strengthen their market position, expand their portfolio, and gain access to new markets.
Key Players in the Esophageal Implant Industry:
Key Developments in the Esophageal Implant Industry:
Attribute | Details |
---|---|
Estimated Market Size (2023) | US$ 147.0 million |
Projected Market Size (2033) | US$ 280.2 million |
Anticipated Growth Rate (2023 to 2033) | 6.7% CAGR |
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2017 to 2022 |
Market Analysis | US$ million for Value and MT for Volume |
Key Regions Covered | North America; Latin America; Europe; Asia Pacific; and Middle East and Africa |
Key Countries Covered | United States, Canada, Mexico, Brazil, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, Australia and New Zealand, Türkiye, South Africa, GCC Countries, Others. |
Key Segments Covered | Product, Application, End User, and Region |
Key Companies Profiled | Boston Scientific; Medtronic; Cook Medical; Taewoong Medical; Micro-Tech (Nanjing) Co., Ltd.; Ella-CS; M.I. Tech; Merit Medical; Xlumena Inc.; Olympus Corporation; Johnson & Johnson; Apollo Endosurgery, Inc.; EndoStim; NDO Surgical, Inc; Mederi Therapeutics; Becton Dickenson & Company; Baxter International (Synovis Surgical Innovations) |
The overall market value could be nearly US$ 147 million in 2023.
The global market is projected to retain its growth rate at 6.7% per year through 2033.
Boston, Medtronic, and Cook Medical are the leading suppliers of Esophageal implants.
GERD treatment is the leading segment which is anticipated to follow 7.4% CAGR till 2033.
The United States to retain its top position with 7.3% CAGR through 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value-Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USP’s 4.3. Technological Roadmap 4.4. Reimbursement Scenario 4.5. Recent Product Approved / Launched 4.6. Regulatory Landscape 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Growing Geriatric Population Rate 5.2.3. Favourable Government Regulations 5.2.4. Rising Demand for Minimally Invasive Surgeries 5.2.5. Technological Advancement 5.2.6. Increasing Prevalence of Oesophageal Cancer 5.2.7. Growing Product Demand For Gastroesophageal Reflux Disease Treatment 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID-19 Crisis - Impact Assessment 6.1. COVID-19 and Impact Analysis 6.1.1. By Product 6.1.2. By Application 6.1.3. By End User 6.1.4. By Region 6.2. 2023 Market Scenario 7. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7.1. Historical Volume (in Units) Analysis, 2017 to 2022 7.2. Current and Future Volume (in Units) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer-Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 8.4. Pricing Assumptions 9. Global Market Demand (in Value or Size in US$ million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 10.3.1. Esophageal Stents 10.3.1.1. Self-Expandable Metal Stents (SEMS) 10.3.1.2. Self-Expandable Plastic Stents (SEPS) 10.3.2. Magnetic Sphincter Augmentation (MSA) Devices 10.3.3. Injectable Bulking Agents 10.3.4. Artificial Esophageal Valves 10.3.4.1. Endoscopic Esophageal Valves 10.3.4.2. Prosthetic Esophageal Valves 10.4. Market Attractiveness Analysis By Product 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 11.3.1. Gastroesophageal Reflux Disease (GERD) 11.3.2. Esophageal Strictures 11.3.3. Esophageal Fistulas 11.3.4. Esophageal Defects 11.3.5. Weakened Esophageal Sphincters 11.4. Market Attractiveness Analysis By Application 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Specialty Clinics 12.3.4. Academic & Research Institutions 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. United States 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Country-Level Analysis & Forecast 14.5.1. United States Market Analysis 14.5.1.1. .Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Application 14.5.1.2.3. By End User 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Application 14.5.2.2.3. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Country-Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. .Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Application 15.5.1.2.3. By End User 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Application 15.5.2.2.3. By End User 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Application 15.5.3.2.3. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. United Kingdom 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Country-Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. .Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Application 16.5.1.2.3. By End User 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Application 16.5.2.2.3. By End User 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Application 16.5.3.2.3. By End User 16.5.4. United Kingdom Market Analysis 16.5.4.1. .Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Application 16.5.4.2.3. By End User 16.5.5. Spain Market Analysis 16.5.5.1. .Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product 16.5.5.2.2. By Application 16.5.5.2.3. By End User 16.5.6. Russia Market Analysis 16.5.6.1. .Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product 16.5.6.2.2. By Application 16.5.6.2.3. By End User 16.5.7. BENELUX Market Analysis 16.5.7.1. .Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product 16.5.7.2.2. By Application 16.5.7.2.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Country-Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. .Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Application 17.5.1.2.3. By End User 17.5.2. Thailand Market Analysis 17.5.2.1. .Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Application 17.5.2.2.3. By End User 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Application 17.5.3.2.3. By End User 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Application 17.5.4.2.3. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Country-Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. .Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Application 18.5.1.2.3. By End User 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Application 18.5.2.2.3. By End User 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Application 18.5.3.2.3. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Country-Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. .Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Application 19.5.1.2.3. By End User 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Application 19.5.2.2.3. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Application 20.3.4. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Application 20.4.4. By End User 20.5. Country-Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. .Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product 20.5.1.2.2. By Application 20.5.1.2.3. By End User 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Application 20.5.2.2.3. By End User 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Application 20.5.3.2.3. By End User 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Product 20.5.4.2.2. By Application 20.5.4.2.3. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Branding and Promotional Strategies, By Key Players 22.3. Key Development Analysis 22.4. Competition Deep Dive 22.4.1. Boston Scientific 22.4.1.1. Overview 22.4.1.2. Product Portfolio 22.4.1.3. Key Financials 22.4.1.4. Sales Footprint 22.4.1.5. SWOT Analysis 22.4.1.6. Strategy Overview 22.4.1.6.1. Marketing Strategy 22.4.1.6.2. Product Strategy 22.4.1.6.3. Channel Strategy 22.4.2. Medtronic 22.4.2.1. Overview 22.4.2.2. Product Portfolio 22.4.2.3. Key Financials 22.4.2.4. Sales Footprint 22.4.2.5. SWOT Analysis 22.4.2.6. Strategy Overview 22.4.2.6.1. Marketing Strategy 22.4.2.6.2. Product Strategy 22.4.2.6.3. Channel Strategy 22.4.3. Cook Medical 22.4.3.1. Overview 22.4.3.2. Product Portfolio 22.4.3.3. Key Financials 22.4.3.4. Sales Footprint 22.4.3.5. SWOT Analysis 22.4.3.6. Strategy Overview 22.4.3.6.1. Marketing Strategy 22.4.3.6.2. Product Strategy 22.4.3.6.3. Channel Strategy 22.4.4. Taewoong Medical 22.4.4.1. Overview 22.4.4.2. Product Portfolio 22.4.4.3. Key Financials 22.4.4.4. Sales Footprint 22.4.4.5. SWOT Analysis 22.4.4.6. Strategy Overview 22.4.4.6.1. Marketing Strategy 22.4.4.6.2. Product Strategy 22.4.4.6.3. Channel Strategy 22.4.5. Micro-Tech (Nanjing) Co., Ltd. 22.4.6. Ella-CS 22.4.6.1. Overview 22.4.6.2. Product Portfolio 22.4.6.3. Key Financials 22.4.6.4. Sales Footprint 22.4.6.5. SWOT Analysis 22.4.6.6. Strategy Overview 22.4.6.6.1. Marketing Strategy 22.4.6.6.2. Product Strategy 22.4.6.6.3. Channel Strategy 22.4.7. M.I. Tech 22.4.7.1. Overview 22.4.7.2. Product Portfolio 22.4.7.3. Key Financials 22.4.7.4. Sales Footprint 22.4.7.5. SWOT Analysis 22.4.7.6. Strategy Overview 22.4.7.6.1. Marketing Strategy 22.4.7.6.2. Product Strategy 22.4.7.6.3. Channel Strategy 22.4.8. Merit Medical 22.4.8.1. Overview 22.4.8.2. Product Portfolio 22.4.8.3. Key Financials 22.4.8.4. Sales Footprint 22.4.8.5. SWOT Analysis 22.4.8.6. Strategy Overview 22.4.8.6.1. Marketing Strategy 22.4.8.6.2. Product Strategy 22.4.8.6.3. Channel Strategy 22.4.9. Xlumena Inc. 22.4.9.1. Overview 22.4.9.2. Product Portfolio 22.4.9.3. Key Financials 22.4.9.4. Sales Footprint 22.4.9.5. SWOT Analysis 22.4.9.6. Strategy Overview 22.4.9.6.1. Marketing Strategy 22.4.9.6.2. Product Strategy 22.4.9.6.3. Channel Strategy 22.4.10. Olympus Corporation 22.4.10.1. Overview 22.4.10.2. Product Portfolio 22.4.10.3. Key Financials 22.4.10.4. Sales Footprint 22.4.10.5. SWOT Analysis 22.4.10.6. Strategy Overview 22.4.10.6.1. Marketing Strategy 22.4.10.6.2. Product Strategy 22.4.10.6.3. Channel Strategy 22.4.11. Johnson & Johnson 22.4.11.1. Overview 22.4.11.2. Product Portfolio 22.4.11.3. Key Financials 22.4.11.4. Sales Footprint 22.4.11.5. SWOT Analysis 22.4.11.6. Strategy Overview 22.4.11.6.1. Marketing Strategy 22.4.11.6.2. Product Strategy 22.4.11.6.3. Channel Strategy 22.4.12. Apollo Endosurgery, Inc. 22.4.12.1. Overview 22.4.12.2. Product Portfolio 22.4.12.3. Key Financials 22.4.12.4. Sales Footprint 22.4.12.5. SWOT Analysis 22.4.12.6. Strategy Overview 22.4.12.6.1. Marketing Strategy 22.4.12.6.2. Product Strategy 22.4.12.6.3. Channel Strategy 22.4.13. EndoStim 22.4.13.1. Overview 22.4.13.2. Product Portfolio 22.4.13.3. Key Financials 22.4.13.4. Sales Footprint 22.4.13.5. SWOT Analysis 22.4.13.6. Strategy Overview 22.4.13.6.1. Marketing Strategy 22.4.13.6.2. Product Strategy 22.4.13.6.3. Channel Strategy 22.4.14. NDO Surgical, Inc 22.4.14.1. Overview 22.4.14.2. Product Portfolio 22.4.14.3. Key Financials 22.4.14.4. Sales Footprint 22.4.14.5. SWOT Analysis 22.4.14.6. Strategy Overview 22.4.14.6.1. Marketing Strategy 22.4.14.6.2. Product Strategy 22.4.14.6.3. Channel Strategy 22.4.15. Mederi Therapeutics 22.4.15.1. Overview 22.4.15.2. Product Portfolio 22.4.15.3. Key Financials 22.4.15.4. Sales Footprint 22.4.15.5. SWOT Analysis 22.4.15.6. Strategy Overview 22.4.15.6.1. Marketing Strategy 22.4.15.6.2. Product Strategy 22.4.15.6.3. Channel Strategy 22.4.16. Becton Dickenson & Company 22.4.16.1. Overview 22.4.16.2. Product Portfolio 22.4.16.3. Key Financials 22.4.16.4. Sales Footprint 22.4.16.5. SWOT Analysis 22.4.16.6. Strategy Overview 22.4.16.6.1. Marketing Strategy 22.4.16.6.2. Product Strategy 22.4.16.6.3. Channel Strategy 22.4.17. Baxter International (Synovis Surgical Innovations) 22.4.17.1. Overview 22.4.17.2. Product Portfolio 22.4.17.3. Key Financials 22.4.17.4. Sales Footprint 22.4.17.5. SWOT Analysis 22.4.17.6. Strategy Overview 22.4.17.6.1. Marketing Strategy 22.4.17.6.2. Product Strategy 22.4.17.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports